Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $61,556.00 |
|---|---|
| Enterprise Value | $986,037.00 |
| Earnings per Share | $-0.05 |
| Beta | 0.23 |
| Outstanding Shares | 615,555,666 |
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 4.17 |
| Enterprise Value to EBIT | -0.86 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.94 |
| Debt to Equity | -0.16 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategicall...